FDA Submits Proposed Collection of Information for Medical Device Adverse Event Program Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act, as part of its Adverse Event Program for Medical Devices, also known as the Medical Product Safety Network (MedSun).